Planet 13 Holdings (PLNH) Non-Current Deferred Tax Liability (2022 - 2026)
Planet 13 Holdings (PLNH) posted quarterly Non-Current Deferred Tax Liability of $663317.0 for Q1 2026, down 46.15% year-over-year from $1.2 million in Q1 2025, and up 30.87% quarter-over-quarter from $506836.0 in Q4 2025.
Planet 13 Holdings (PLNH) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Non-Current Deferred Tax Liability for 5 consecutive years, with $663317.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 46.15% year-over-year to $663317.0; the TTM figure through Mar 2026 stood at $663317.0 (down 46.15% YoY), while the FY2025 annual figure was $506836.0, down 69.87% from the prior year.
- Non-Current Deferred Tax Liability improved to $663317.0 in Q1 2026 per PLNH's latest filing, from $506836.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $3.9 million in Q3 2024 and bottomed at $11504.0 in Q3 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $1.9 million across 5 years, with a median of $1.5 million in 2023.
- Annual changes were most pronounced in 2024 — Non-Current Deferred Tax Liability jumped 165.91% — and 2025, when it tumbled 99.71%.
- Planet 13 Holdings' Non-Current Deferred Tax Liability stood at $1.5 million in 2022, then surged by 136.12% to $3.5 million in 2023, then sank by 52.1% to $1.7 million in 2024, then sank by 69.87% to $506836.0 in 2025, then surged by 30.87% to $663317.0 in 2026.
- Business Quant data shows PLNH's Non-Current Deferred Tax Liability at $663317.0 in Q1 2026, $506836.0 in Q4 2025, and $11504.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Planet 13 Holdings | 52.64 Mn | 36.16 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 653,909.00 |
| Jun 30, 2026 | 653,909.00 |
| Mar 31, 2026 | 663,317.00 |
| Mar 31, 2026 | 663,317.00 |
| Dec 31, 2025 | 506,836.00 |
| Dec 31, 2025 | 506,836.00 |
| Sep 30, 2025 | 11,504.00 |
| Sep 30, 2025 | 11,504.00 |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Sep 30, 2024 | 3.94 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | 3.51 Mn |
| Mar 31, 2024 | 3.51 Mn |